Real-World Study Evaluates Use of Palliative Chemotherapy in Cervical Cancer
Limited access to targeted therapies and immunotherapies as well as the aggressive nature of metastatic or recurrent cervical cancer are a few of the barriers to care that affect patients internationally; especially those who seek treatment in low- and middle-income countries. According to a recent analysis of real-world data, those barriers and access to effective palliative chemotherapy treatments play a role both in patient access to cervical cancer care and survival outcomes. ...
Advertisement

Latest News

Advertisement
Advertisement
Our Contributors

Expert Interviews

Conference Highlights

Lisa Hwa, APRN, CNP, DNP, MSHematology & Blood Cancer | October 23, 2024
Lisa Hwa, APRN, CNP, DNP, MS, said the comprehensive fellowships will help prepare APPs working in complex specialties.
View More
Cecilia BrownBreast Cancer | October 14, 2024
Learn how a team developed a predictive model for breast cancer using cfDNA low-pass whole genome sequencing.
Cecilia BrownBreast Cancer | October 10, 2024
The study analyzed quality-adjusted time without symptoms of disease progression or toxicity of treatment, known as Q-TWiST.
Amanda Brink, DNP, APRN, FNP-BC, AOCNPTreatment | October 9, 2024
Patients who received the vaccine within 100 days of starting an immune checkpoint inhibitor showed improved survival.

Network Websites